TerumoMEX:4543N 91 Gross Margin % is 49.62% as of Mar. 2026, which is 7% below its 10-year median of 53.24. GuruFocus rates MEX:4543N with a GF Score™ of 91/100 and a GF Value™ of MXN372.38 (Significantly Undervalued). Among 805 Medical Devices & Instruments companies, Terumo ranks better than 50.81% on this metric.
Gross Margin % is calculated as gross profit divided by its revenue. Terumo's Gross Profit for the
three
months ended in Mar. 2026 was MXN16,935 Mil. Terumo's Revenue for the
three
months ended in Mar. 2026 was MXN34,128 Mil. Therefore, Terumo's Gross Margin % for the quarter that ended in Mar. 2026 was 49.62%.
The historical rank and industry rank for Terumo's Gross Margin % or its related term are showing as below:
MEX:4543N'
s Gross Margin % Range Over the Past 10 Years
Min: 50.89 Med: 53.24 Max: 54.69
Current: 52.54
During the past 13 years, the highestGross Margin % of Terumo was 54.69%. The lowest was 50.89%. And the median was 53.24%.
MEX:4543N's Gross Margin % is ranked better than 50.81% of 805
companies
in the Medical Devices & Instruments industry
Industry Median: 52.07
vs MEX:4543N: 52.54
Terumo had a gross margin of 49.62% for the quarter that ended in Mar. 2026 => Durable competitive advantage
The 5-Year average Growth Rate of Gross Margin for Terumo was 0.10% per year.
Terumo (MEX:4543N) Gross Margin % Explanation
Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.
Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %
1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key
Terumo had a gross margin of 49.62% for the quarter that ended in Mar. 2026 => Durable competitive advantage
Be Aware
If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.
Terumo Gross Margin % Related Terms
Terumo Gross Margin % Historical Data
* Premium members only.
The historical data trend for Terumo's Gross Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MEX:4543N vs ISRG, BDX, MDLN: Gross Margin % Comparison
For the Medical Instruments & Supplies subindustry, Terumo's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Terumo Gross Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Terumo's Gross Margin % distribution charts can be found below:
* The bar in red indicates where Terumo's Gross Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.
Terumo (MEX:4543N) has a Gross Margin % of 49.62% as of Mar. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Terumo and its competitors. This is near median its historical median of 53.24. Over the past decade, Terumo's Gross Margin % has ranged from 50.89 to 54.69. According to the industry distribution chart, Terumo ranks #396 out of 805 companies in the Medical Devices & Instruments industry, placing it in the top 49.2%.
Is Terumo's Gross Margin % too high?
Terumo's current Gross Margin % of 49.62% is near median its 10-year median of 53.24. Over the past 10 years, this metric has ranged from a low of 50.89 to a high of 54.69. The Medical Devices & Instruments industry median Gross Margin % is 52.07. Terumo's value of 49.62% is 4.7% below this industry median. Based on the distribution chart, Terumo ranks #396 out of 805 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Terumo has a GF Score™ of 91/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Terumo's Gross Margin % compare to ISRG and BDX?
According to the Medical Devices & Instruments industry distribution chart, Terumo ranks #396 out of 805 companies for Gross Margin %. This puts Terumo in the upper half of its industry. The industry median Gross Margin % is 52.07. Terumo's value of 49.62% is 4.7% below this benchmark. Historically, Terumo's own Gross Margin % has ranged from 50.89 to 54.69 over the past decade. While the company's 10-year median is 53.24 vs. the industry median of 52.07, Terumo has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.07, based on 805 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Terumo's current Gross Margin % of 49.62% is 4.7% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Terumo and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.07 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Terumo's current Gross Margin % is 49.62%, which is near median its own 10-year median of 53.24. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terumo stock overvalued right now?
Based on GuruFocus' analysis, Terumo (MEX:4543N) is currently considered Significantly Undervalued. The stock's GF Value™ is MXN372.38, compared to a current price of MXN261.28 — trading 29.8% below its estimated fair value. The current Gross Margin % is 49.62%, which is near median its 10-year median of 53.24 and 4.7% below the Medical Devices & Instruments industry median of 52.07. Terumo's overall GF Score™ is 91/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Terumo (MEX:4543N), the current Gross Margin % is 49.62% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Terumo (MEX:4543N) Overvalued in 2026?
Based on GuruFocus' analysis, Terumo stock appears to be undervalued.
The current stock price of MXN261.28 is trading 29.8% below its estimated GF Value™ of MXN372.38.
GuruFocus considers Terumo to be Significantly Undervalued.
Key valuation signals for MEX:4543N:
Gross Margin %: 49.62% (near median its 10-year median of 53.24)
GF Value™: MXN372.38 vs. price of MXN261.28 (29.8% below fair value)
Industry Position: 4.7% below the Medical Devices & Instruments median (#396 of 805)
No single metric tells the full story. See the MEX:4543N stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
91GF Score
Get the complete analysis for MEX:4543N
Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
MEX:4543N has been successfully added to your 
